EUVIMEDEUVIMED entdecken
Open Access

Knockdown of deleterious miRNA in progenitor cell–derived small extracellular vesicles enhances tissue repair in myocardial infarction

Hyun-Ji Park iD, Jessica R Hoffman iD, Milton E Brown iD, Sruti Bheri, Olga Brazhkina iD, Young Hoon Son iD, Michael E Davis iD

Science Advances · 2023

DOI: 10.1126/sciadv.abo4616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Hyun-Ji Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine and Georgia Institute of Technology, Atlanta, GA 30322, …. Hauptthemen laut MEDLINE: Myocardial Infarction, Extracellular Vesicles, MicroRNAs. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small extracellular vesicles (sEVs) play a critical role in cardiac cell therapy by delivering molecular cargo and mediating cellular signaling. Among sEV cargo molecule types, microRNA (miRNA) is particularly potent and highly heterogeneous. However, not all miRNAs in sEV are beneficial. Two previous studies using computational modeling identified miR-192-5p and miR-432-5p as potentially deleterious in cardiac function and repair. Here, we show that knocking down miR-192-5p and miR-432-5p in cardiac c-kit + cell (CPC)–derived sEVs enhances the therapeutic capabilities of sEVs in vitro and in a rat in vivo model of cardiac ischemia reperfusion. miR-192-5p– and miR-432-5p–depleted CPC-sEVs enhance cardiac function by reducing fibrosis and necrotic inflammatory responses. miR-192-5p–depleted CPC-sEVs also enhance mesenchymal stromal cell–like cell mobilization. Knocking down deleterious miRNAs from sEV could be a promising therapeutic strategy for treatment of chronic myocardial infarction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionExtracellular VesiclesMicroRNAsAnimalsRatsStem CellsHeartAnti-Arrhythmia AgentsCardiotonic Agents

Substanzen

Anti-Arrhythmia AgentsCardiotonic AgentsMicroRNAs

Autor:innen und Institutionen

  • Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine and Georgia Institute of Technology, Atlanta, GA 30322, USA.
  • Department of Molecular Science and Technology, Ajou University, Suwon 16499, South Korea.
  • Molecular and Systems Pharmacology Graduate Training Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA 30322, USA.
  • Children's Heart Research and Outcomes (HeRO) Center, Children's Healthcare of Atlanta and Emory University, Atlanta, GA 30322, USA.

ORCID-Profile: Hyun-Ji Park, Jessica R Hoffman, Milton E Brown, Olga Brazhkina, Young Hoon Son, Michael E Davis

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Park, H. J., Hoffman, J. R., Brown, M. E., Bheri, S., Brazhkina, O., Son, Y. H., & Davis, M. E. (2023). Knockdown of deleterious miRNA in progenitor cell–derived small extracellular vesicles enhances tissue repair in myocardial infarction. Science Advances. https://doi.org/10.1126/sciadv.abo4616

Vancouver

Park HJ, Hoffman JR, Brown ME, Bheri S, Brazhkina O, Son YH, et al. Knockdown of deleterious miRNA in progenitor cell–derived small extracellular vesicles enhances tissue repair in myocardial infarction. Science Advances. 2023. doi:10.1126/sciadv.abo4616

BibTeX
@article{Park2023,
  author = {Park, Hyun-Ji and Hoffman, Jessica R and Brown, Milton E and Bheri, Sruti and Brazhkina, Olga and Son, Young Hoon and Davis, Michael E},
  title = {Knockdown of deleterious miRNA in progenitor cell–derived small extracellular vesicles enhances tissue repair in myocardial infarction},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.abo4616}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche